PTGS2 and neoplasm: In order to investigate the effects of COX-2/exo-miR-1290/CUL3 pathway on CAFs activation and tumor progression in vivo, we established tumor xenografts in nude mice by subcutaneously implanting A549-COX-2 cells and NIH-3T3 cells with or without stably expressing CUL3.